Healthcare

Chinese Medical Cosmetology Platform SoYoung Seeks For US IPO

Eudora Wang - October 12, 2018 — 13:51

Warburg Pincus Invests In Chinese Assisted Reproduction Company Jinxin Fertility

Sophy Yang - October 9, 2018 — 17:43

Sequoia Invests $15M In Chinese Healthcare AI Start-up Deep Intelligent Pharma

Sophy Yang - October 9, 2018 — 11:27

China Faces Public Health Crisis As HIV/AIDS Cases Surge By 14% With Universities Hardest Hit

Sophy Yang - October 8, 2018 — 16:44

Lyfe Capital Leads $44M Round In Chinese Endoscopy Solution Provider Aohua Endoscopy

Sophy Yang - September 29, 2018 — 21:31

Tencent-Backed WeDoctor Teams Up With Fullerton Healthcare To Set Up O2O Healthcare Platform

Eudora Wang - September 27, 2018 — 13:17

Ping An-Backed Fund Joins $70M Financing Round In Israeli Medical Start-Up MeMed

Eudora Wang - September 21, 2018 — 14:35

Chinese Biotech Firm WuXi AppTec Eyes $1B Hong Kong IPO

Eudora Wang - September 20, 2018 — 13:46

111 Inc.’s Xu Weihao: Online Healthcare Platform With Govt To Tackle China’s Medical Problems

Eudora Wang - September 19, 2018 — 15:35

Chinese Plastic Surgery Chain BeauCare Clinics Raises $58M Series C Round From Sino-Ocean Capital

Sophy Yang - September 18, 2018 — 17:47

Chinese Healthcare Platform 111 Inc. Raises $100.5M In US IPO

Eudora Wang - September 17, 2018 — 09:13

Li Ka-shing-backed US Start-up Driver Launches Paid Service To Revamp Cancer Care

Sophy Yang - September 7, 2018 — 12:01

GTJA Investment Group Leads $130M Series B Round In Chinese Online B2C Pharmacy Jianke

Sophy Yang - September 5, 2018 — 12:04

Hong Kong-Based Consortium Reportedly To Buy Australian Fertility Treatment Provider For US$509M

Eudora Wang - August 31, 2018 — 14:22

Qiming, Hillhouse Lead $55M Series C Round In Chinese Biotech Firm Jacobio Pharmaceuticals

Sophy Yang - August 30, 2018 — 13:31

GIC Leads $85M Series B Round In Chinese Biotech Firm Harbour BioMed

Sophy Yang - August 27, 2018 — 14:01

CDH Investments-backed Chinese Biotechnology Firm Mabpharm Files For Hong Kong IPO

Sophy Yang - August 24, 2018 — 11:15

China Orient Asset Management’s Subsidiary Leads Series A Round In Reproductive Healthcare Firm Jinqi Group

Yimian Wu - August 24, 2018 — 10:12

China Biologic Receives Higher Counter Bid From Investor Group Led By Ex-CEO

Eudora Wang - August 21, 2018 — 14:26

Alibaba Health Invests $121M In Chinese Pharmaceutical Retail Chain Business

Yimian Wu - August 21, 2018 — 12:34

Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

Yimian Wu - August 21, 2018 — 11:01

Ping An Good Doctor To Set Up Joint Venture With Grab In Southeast Asia

Li Dongmei - August 16, 2018 — 18:20

Chinese Online Drugstore 111 Inc. Files For $200M US IPO

Sophy Yang - August 16, 2018 — 11:25

Chinese Bio-pharmaceutical Company TOT Biopharm Raises $102M Series B Round

Sophy Yang - August 10, 2018 — 11:53

Qiming Venture Leads $17M Series A Round In Chinese Biotech Firm CureGenetics

Sophy Yang - August 7, 2018 — 11:03

Long Hill Capital Sees Opportunities In China’s Underserved Healthcare Sector

Yimian Wu - August 6, 2018 — 21:18

Decheng Capital Leads $30M Series C Round In China’s Impact Therapeutics

Yimian Wu - August 3, 2018 — 17:26

Hillhouse Capital, Decheng Capital Lead $60M Series B Round In US DNA Sequencing Platform Developer Omniome

Yimian Wu - August 2, 2018 — 10:20

Legend Capital Joins China Renaissance To Lead $293M Investment In Chinese Diagnostics Medical Corporation

Yimian Wu - August 1, 2018 — 17:07

Chinese Medical Solution Provider Medlinker Raises US$147M in Series D Round

Sophy Yang - July 31, 2018 — 11:00

Consumer Healthcare Platform Igengmei Raises $50M Series D Round

Sophy Yang - July 30, 2018 — 16:29

Healthcare

China’s Everbright Healthcare Fund III Reaches $155M First Closing

Carlyle Invests In Chinese Clinical Labs Operator Adicon

Temasek-Backed Biotech Firm Innovent Seeks To Raise Up To $500M In HK IPO

Chinese Medical Cosmetology Platform SoYoung Seeks For US IPO

Warburg Pincus Invests In Chinese Assisted Reproduction Company Jinxin Fertility

Sequoia Invests $15M In Chinese Healthcare AI Start-up Deep Intelligent Pharma

China Faces Public Health Crisis As HIV/AIDS Cases Surge By 14% With Universities Hardest Hit

Lyfe Capital Leads $44M Round In Chinese Endoscopy Solution Provider Aohua Endoscopy

Tencent-Backed WeDoctor Teams Up With Fullerton Healthcare To Set Up O2O Healthcare Platform

Ping An-Backed Fund Joins $70M Financing Round In Israeli Medical Start-Up MeMed

Chinese Biotech Firm WuXi AppTec Eyes $1B Hong Kong IPO

111 Inc.’s Xu Weihao: Online Healthcare Platform With Govt To Tackle China’s Medical Problems

Chinese Plastic Surgery Chain BeauCare Clinics Raises $58M Series C Round From Sino-Ocean Capital

Chinese Healthcare Platform 111 Inc. Raises $100.5M In US IPO

Li Ka-shing-backed US Start-up Driver Launches Paid Service To Revamp Cancer Care

GTJA Investment Group Leads $130M Series B Round In Chinese Online B2C Pharmacy Jianke

Hong Kong-Based Consortium Reportedly To Buy Australian Fertility Treatment Provider For US$509M

Qiming, Hillhouse Lead $55M Series C Round In Chinese Biotech Firm Jacobio Pharmaceuticals

GIC Leads $85M Series B Round In Chinese Biotech Firm Harbour BioMed

CDH Investments-backed Chinese Biotechnology Firm Mabpharm Files For Hong Kong IPO

China Orient Asset Management’s Subsidiary Leads Series A Round In Reproductive Healthcare Firm Jinqi Group

China Biologic Receives Higher Counter Bid From Investor Group Led By Ex-CEO

Alibaba Health Invests $121M In Chinese Pharmaceutical Retail Chain Business

Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

Ping An Good Doctor To Set Up Joint Venture With Grab In Southeast Asia

Chinese Online Drugstore 111 Inc. Files For $200M US IPO

Chinese Bio-pharmaceutical Company TOT Biopharm Raises $102M Series B Round

Qiming Venture Leads $17M Series A Round In Chinese Biotech Firm CureGenetics

Long Hill Capital Sees Opportunities In China’s Underserved Healthcare Sector

Decheng Capital Leads $30M Series C Round In China’s Impact Therapeutics

Hillhouse Capital, Decheng Capital Lead $60M Series B Round In US DNA Sequencing Platform Developer Omniome

Legend Capital Joins China Renaissance To Lead $293M Investment In Chinese Diagnostics Medical Corporation

Chinese Medical Solution Provider Medlinker Raises US$147M in Series D Round

Consumer Healthcare Platform Igengmei Raises $50M Series D Round